Q/C Technologies, Inc. (the Company ) has historically been engaged in the development and commercialization of therapeutic platforms based on well-defined biological targets, including Isomyosamine and Supera-CBD. More recently, the Company has shifted its business strategy to focus on energy-efficient blockchain and cryptocurrency infrastructure through quantum-class laser-based computing.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$17M
▲ +50.2% YoY
Op. Margin
–
ROIC
-61.03%
▲ +23.0pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$11M
Op. Cash Flow (TTM)
-$9M
▼ -1.0% YoY
Net Debt
-$11M
Net Cash Position
Cash & Equiv.
$11M
3Y CAGR: -18.9%
Continue Research
Peers
In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with QCLS
Q/C Technologies (QCLS) in three numbers
Questions about Q/C Technologies
Is Q/C Technologies (QCLS) overvalued?
Q/C Technologies trades at 0.01 times earnings. Intrinsiqq's fair value calculator has no opening value for QCLS, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Q/C Technologies a high-quality business?
Q/C Technologies scores 20 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is net debt at -$11M, and its weakest is return on capital at -61.0%. The Quality tab shows every check against its target.
Does Q/C Technologies (QCLS) pay a dividend?
No. Q/C Technologies (QCLS) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 12 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in QCLS's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing QCLS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.